Area of research
Internal Medicine · Hematology
Research interest
Research focused on Pulmonary embolism and Kidney disease, with related work in Fondaparinux, Rivaroxaban, Fever of unknown origin. Notable publications include 'Duration of anticoagulation after venous thromboembolism in real world clinical practice', 'Retrievable vena cava filters: a clinical review', and 'Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial'.
Fever of unknown origin (FUO) FADOI-SIMIT Italian registry: can demographics, comorbidities, and clinical variables predict the etiology of classic FUO?—a prospective Italian study
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial
Duration of anticoagulation after venous thromboembolism in real world clinical practice
Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients: a rebuttal
Retrievable vena cava filters: a clinical review
In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy